Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Clinical Laboratory Improvement Amendments Waiver Applications, 48172 [2013-19053]

Download as PDF 48172 Federal Register / Vol. 78, No. 152 / Wednesday, August 7, 2013 / Notices ANNUAL BURDEN ESTIMATES Instrument Number of respondents Number of responses per respondent Average burden hours per response Total burden hours None ................................................................................................................ 1,113,719 1 0.17 189,332.23 Estimated Total Annual Burden Hours: 189,332.23. In compliance with the requirements of Section 506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Administration for Children and Families is soliciting public comment on the specific aspects of the information collection described above. Comments may be forwarded by writing to the Administration for Children and Families, Office of Planning, Research and Evaluation, 370 L’Enfant Promenade SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. Email address: infocollection@acf.hhs.gov. All requests should be identified by the title of the information collection. The Department specifically requests comments on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (c) the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Consideration will be given to comments and suggestions submitted within 60 days of this publication. SUMMARY: Robert Sargis, Reports Clearance Officer. BILLING CODE 4160–01–P [FR Doc. 2013–19058 Filed 8–6–13; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4184–01–P mstockstill on DSK4VPTVN1PROD with NOTICES [Docket No. FDA–2012–N–0937] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Clinical Laboratory Improvement Amendments Waiver Applications ACTION: Food and Drug Administration, Notice. VerDate Mar<15>2010 17:03 Aug 06, 2013 Jkt 229001 [FR Doc. 2013–19053 Filed 8–6–13; 8:45 am] [Docket No. FDA–2012–D–1092] Food and Drug Administration HHS. Dated: August 1, 2013. Leslie Kux, Assistant Commissioner for Policy. Food and Drug Administration DEPARTMENT OF HEALTH AND HUMAN SERVICES AGENCY: The Food and Drug Administration (FDA) is announcing that a collection of information entitled ‘‘Clinical Laboratory Improvement Amendments Waiver Applications’’ has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Daniel Gittleson, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50– 400B, Rockville, MD 20850, 301–796– 5156, Daniel.Gittleson@fda.hhs.gov. SUPPLEMENTARY INFORMATION: On April 23, 2013, the Agency submitted a proposed collection of information entitled ‘‘Clinical Laboratory Improvement Amendments Waiver Applications’’ to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910–0598. The approval expires on July 31, 2016. A copy of the supporting statement for this information collection is available on the Internet at https://www.reginfo.gov/ public/do/PRAMain. Minimizing Risk for Children’s Toy Laser Products; Draft Guidance for Industry and Food and Drug Administration Staff; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice. The Food and Drug Administration (FDA) is announcing the availability of the draft guidance entitled ‘‘Minimizing Risk for Children’s SUMMARY: PO 00000 Frm 00038 Fmt 4703 Sfmt 4703 Toy Laser Products.’’ This draft guidance is to inform manufacturers of laser products, FDA headquarters and field personnel, and the public of the Center for Devices and Radiological Health’s (CDRH) proposed approach on the safety of toy laser products. This draft guidance is not final nor is it in effect at this time. DATES: Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the Agency considers your comment on this draft guidance before it begins work on the final version of the guidance, submit either electronic or written comments on the draft guidance by November 5, 2013. Submit written requests for single copies of the draft guidance document entitled ‘‘Minimizing Risk for Children’s Toy Laser Products’’ to the Division of Small Manufacturers, International and Consumer Assistance, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 4613, Silver Spring, MD 20993– 0002. Send one self-addressed adhesive label to assist that office in processing your request, or fax your request to 301– 847–8149. See the SUPPLEMENTARY INFORMATION section for information on electronic access to the guidance. Submit electronic comments on the draft guidance to https:// www.regulations.gov. Submit written comments to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Identify comments with the docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Robert J. Doyle, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 4672, Silver Spring, MD 20993–0002, 301–796–5863. ADDRESSES: I. Background This draft guidance is to inform manufacturers of laser products, FDA headquarters and field personnel, and the public of CDRH’s proposed approach on the safety of children’s toy laser products. Lasers with outputs above certain levels that are operated in E:\FR\FM\07AUN1.SGM 07AUN1

Agencies

[Federal Register Volume 78, Number 152 (Wednesday, August 7, 2013)]
[Notices]
[Page 48172]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-19053]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2012-N-0937]


Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Clinical Laboratory Improvement 
Amendments Waiver Applications

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Clinical Laboratory Improvement 
Amendments Waiver Applications'' has been approved by the Office of 
Management and Budget (OMB) under the Paperwork Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT: Daniel Gittleson, Office of 
Information Management, Food and Drug Administration, 1350 Piccard Dr., 
PI50-400B, Rockville, MD 20850, 301-796-5156, 
Daniel.Gittleson@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: On April 23, 2013, the Agency submitted a 
proposed collection of information entitled ``Clinical Laboratory 
Improvement Amendments Waiver Applications'' to OMB for review and 
clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, 
and a person is not required to respond to, a collection of information 
unless it displays a currently valid OMB control number. OMB has now 
approved the information collection and has assigned OMB control number 
0910-0598. The approval expires on July 31, 2016. A copy of the 
supporting statement for this information collection is available on 
the Internet at https://www.reginfo.gov/public/do/PRAMain.

    Dated: August 1, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-19053 Filed 8-6-13; 8:45 am]
BILLING CODE 4160-01-P